Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.23 trillion and total revenue of $112.67 billion.
Market Cap
1.23T
Revenue
112.67B
Profits
-39.48B
PE Ratio
n/a
Profit Margin
-35.04%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.26B | 1.70% | 2,026,324 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.96B | 0.19% | 804,667 | 15.53B |
| 3 | ARGX | argenx SE | 52.43B | 1.65% | 264,376 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 41.13B | 6.03% | 1,614,237 | - |
| 5 | ONC | BeOne Medicines AG | 35.91B | 2.94% | 385,279 | 5.74B |
| 6 | RPRX | Royalty Pharma plc | 33.10B | 0.54% | 3,684,158 | 2.44B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.30B | -0.60% | 3,107,851 | 4.80B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.88B | 3.81% | 5,880,072 | 8.26M |
| 9 | INCY | Incyte Corporation | 24.45B | 1.83% | 2,077,575 | 5.82B |
| 10 | BNTX | BioNTech SE | 23.10B | -0.98% | 1,999,840 | 3.03B |
| 11 | MRNA | Moderna, Inc. | 22.75B | 3.36% | 3,999,813 | 2.23B |
| 12 | INSM | Insmed Incorporated | 21.40B | 0.30% | 4,290,652 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.76B | 1.19% | 1,320,542 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.98B | 3.99% | 1,895,112 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.12B | 0.47% | 791,826 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.04B | 2.64% | 1,686,928 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.08B | 1.71% | 2,729,798 | 2.38B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.62B | 4.16% | 2,031,048 | 669.50M |
| 19 | CORT | Corcept Therapeutics Incorporated | 11.87B | -2.66% | 1,265,969 | 830.81M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.74B | 1.20% | 1,239,096 | 3.24B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | 5.30% | 442,336 | 1.28B |
| 22 | TECH | Bio-Techne Corporation | 11.23B | -0.07% | 3,039,601 | 1.21B |
| 23 | SMMT | Summit Therapeutics Inc. | 10.98B | 5.44% | 3,999,910 | - |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.92B | 0.54% | 473,473 | 708.24M |
| 25 | ABVX | ABIVAX Société Anonyme | 10.79B | 0.33% | 634,794 | 5.67M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.67B | 2.83% | 2,447,470 | 105.82M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.07B | 0.06% | 2,377,912 | - |
| 28 | HALO | Halozyme Therapeutics, Inc. | 9.87B | 1.17% | 1,475,930 | 1.51B |
| 29 | KRYS | Krystal Biotech, Inc. | 9.61B | 3.90% | 534,611 | 440.48M |
| 30 | SYRE | Spyre Therapeutics, Inc. | 9.23B | 10.54% | 831,889 | - |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.15B | 1.06% | 2,688,207 | 874.09M |
| 32 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.89B | 0.12% | 2,725,848 | 42.16M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 8.73B | 2.67% | 634,666 | 74.06M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | 1.49% | 301,894 | 7.46M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 8.59B | 4.07% | 601,334 | 51.48M |
| 36 | IMVT | Immunovant, Inc. | 8.12B | 2.21% | 990,612 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.90B | 2.17% | 868,122 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 7.32B | 10.24% | 4,748,565 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | 2.92% | 1,643,705 | 239.92M |
| 40 | IBRX | ImmunityBio, Inc. | 7.28B | -2.80% | 19,006,776 | 165.79M |
| 41 | TGTX | TG Therapeutics, Inc. | 6.91B | 5.56% | 2,865,349 | 799.54M |
| 42 | ERAS | Erasca, Inc. | 6.38B | 3.03% | 4,759,030 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.36B | -0.25% | 591,577 | 569.61M |
| 44 | CGON | CG Oncology, Inc. | 6.30B | 3.25% | 883,009 | 5.07M |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.19B | 2.81% | 639,245 | 7.50M |
| 46 | BLTE | Belite Bio, Inc | 6.19B | 1.60% | 105,519 | - |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 6.04B | 4.13% | 636,619 | 1.90M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | 3.00% | 329,154 | 274.48M |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.92B | 3.52% | 621,227 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.77B | 1.44% | 1,420,924 | 1.01B |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.73B | 4.23% | 767,360 | - |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.62B | 1.27% | 1,861,957 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 5.23B | 7.06% | 2,142,950 | 13.39M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.21B | 1.89% | 2,464,273 | 591.33M |
| 55 | DYN | Dyne Therapeutics, Inc. | 4.85B | 2.89% | 2,774,190 | - |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | 16.48% | 4,187,480 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.65B | 6.01% | 2,440,366 | 1.14B |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.57B | 5.71% | 357,078 | - |
| 59 | CAI | Caris Life Sciences, Inc. | 4.55B | -1.35% | 4,844,422 | 907.29M |
| 60 | CELC | Celcuity Inc. | 4.51B | 5.44% | 713,874 | - |
| 61 | MANE | Veradermics, Incorporated | 4.48B | 5.29% | 1,702,714 | - |
| 62 | ELVN | Enliven Therapeutics, Inc. | 4.27B | 5.29% | 2,527,882 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.26B | 4.05% | 2,054,378 | 10.68M |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.25B | 7.90% | 1,869,894 | 56.99M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.84B | 1.01% | 1,700,844 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.84B | 4.41% | 993,493 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.70B | 0.63% | 2,565,828 | 1.14B |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.62B | 4.27% | 845,207 | 236.00M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.53B | 2.65% | 876,742 | - |
| 70 | ALMS | Alumis Inc. | 3.46B | 3.83% | 754,351 | 8.40M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.44B | 2.69% | 116,831 | 803.79M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.43B | 2.01% | 1,250,309 | 234.13M |
| 73 | MBX | MBX Biosciences, Inc. | 3.37B | 9.77% | 695,953 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 0.35% | 1,939,067 | 415.62M |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.22B | 0.22% | 1,080,328 | 22.57M |
| 76 | CLDX | Celldex Therapeutics, Inc. | 3.07B | 3.61% | 1,027,383 | 865.00K |
| 77 | QURE | uniQure N.V. | 3.03B | -0.86% | 1,287,329 | 18.67M |
| 78 | IRON | Disc Medicine, Inc. | 2.99B | 1.95% | 380,026 | - |
| 79 | IMNM | Immunome, Inc. | 2.84B | 8.91% | 1,801,989 | 4.02M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.82B | 9.42% | 2,151,053 | 156.04M |
| 81 | KOD | Kodiak Sciences Inc. | 2.68B | 7.68% | 709,013 | - |
| 82 | TRVI | Trevi Therapeutics, Inc. | 2.66B | 4.75% | 2,484,502 | - |
| 83 | ATAI | AtaiBeckley Inc. | 2.66B | - | 6,320,180 | 3.49M |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -0.34% | 541,861 | 535.08M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.56B | 6.33% | 1,191,549 | 36.77M |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | 3.16% | 2,103,416 | 717.00M |
| 87 | NKTR | Nektar Therapeutics | 2.46B | 3.07% | 717,892 | 55.63M |
| 88 | VCEL | Vericel Corporation | 2.37B | 0.63% | 440,777 | 306.30M |
| 89 | PHVS | Pharvaris N.V. | 2.37B | 5.02% | 250,541 | - |
| 90 | KLRA | Kailera Therapeutics, Inc. | 2.35B | 4.56% | 399,005 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | 2.79% | 663,821 | - |
| 92 | PGEN | Precigen, Inc. | 2.33B | -1.21% | 8,015,238 | 85.72M |
| 93 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | 5.26% | 5,089,754 | - |
| 94 | VRDN | Viridian Therapeutics, Inc. | 2.30B | 7.92% | 2,168,696 | 70.92M |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 8.93% | 1,991,432 | 959.90M |
| 96 | SION | Sionna Therapeutics, Inc. | 2.25B | 1.38% | 913,011 | - |
| 97 | NUVB | Nuvation Bio Inc. | 2.24B | 4.55% | 4,652,386 | 143.05M |
| 98 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 7.96% | 279,027 | - |
| 99 | COAG | Hemab Therapeutics Holdings, Inc. | 2.17B | 3.38% | 484,692 | - |
| 100 | VERA | Vera Therapeutics, Inc. | 2.15B | -7.07% | 5,136,555 | - |
| 101 | ZLAB | Zai Lab Limited | 2.08B | 1.71% | 290,021 | 453.28M |
| 102 | BHVN | Biohaven Ltd. | 2.07B | 2.84% | 2,414,540 | - |
| 103 | ADMA | ADMA Biologics, Inc. | 2.07B | 1.95% | 2,820,371 | 509.86M |
| 104 | STOK | Stoke Therapeutics, Inc. | 2.04B | 7.14% | 1,319,907 | 27.59M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 2.02B | 3.46% | 398,034 | 20.00M |
| 106 | NBTX | Nanobiotix S.A. | 2.00B | 1.62% | 91,603 | 38.27M |
| 107 | GHRS | GH Research PLC | 2.00B | 3.30% | 632,270 | - |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.98B | 0.93% | 378,123 | 10.00M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | 7.27% | 3,701,942 | 7.47M |
| 110 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 1.04% | 10,682,083 | 285.61M |
| 111 | URGN | UroGen Pharma Ltd. | 1.94B | 3.45% | 734,380 | 140.49M |
| 112 | TYRA | Tyra Biosciences, Inc. | 1.93B | 1.53% | 396,451 | - |
| 113 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | 2.47% | 980,968 | 298.30M |
| 114 | MESO | Mesoblast Limited | 1.90B | 2.28% | 119,306 | 65.38M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 3.47% | 1,046,548 | 98.34M |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.89B | 2.26% | 2,231,545 | 52.06M |
| 117 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.07% | 1,058,780 | - |
| 118 | ABCL | AbCellera Biologics Inc. | 1.86B | 4.46% | 3,968,395 | 79.21M |
| 119 | DMRA | Damora Therapeutics, Inc. | 1.85B | 5.11% | 551,073 | - |
| 120 | GENB | Generate Biomedicines, Inc. | 1.83B | -0.42% | 304,056 | 30.30M |
| 121 | KARD | Kardigan, Inc. | 1.83B | 2.60% | 136,916 | - |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -1.08% | 331,483 | 1.20B |
| 123 | SEPN | Septerna, Inc. | 1.76B | 11.44% | 398,821 | 72.26M |
| 124 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 4.09% | 21,577,753 | 66.41M |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.73B | 3.21% | 2,876,949 | 2.18B |
| 126 | BCAX | Bicara Therapeutics Inc. | 1.71B | 1.40% | 815,071 | - |
| 127 | FTRE | Fortrea Holdings Inc. | 1.71B | -5.02% | 2,323,586 | 2.68B |
| 128 | IMCR | Immunocore Holdings plc | 1.69B | 2.50% | 576,248 | 412.81M |
| 129 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -0.83% | 2,043,885 | 252.25M |
| 130 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.66B | 0.16% | 1,608,554 | 204.73M |
| 131 | ANAB | AnaptysBio, Inc. | 1.63B | 2.74% | 417,427 | 232.39M |
| 132 | ZYME | Zymeworks Inc. | 1.63B | 4.49% | 355,676 | 81.26M |
| 133 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | -0.32% | 689,966 | - |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 5.11% | 4,339,794 | 66.09M |
| 135 | VIR | Vir Biotechnology, Inc. | 1.55B | 3.03% | 1,708,584 | 65.50M |
| 136 | INVA | Innoviva, Inc. | 1.54B | 0.43% | 564,637 | 420.69M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.53B | 1.02% | 367,352 | 20.00M |
| 138 | AAPG | Ascentage Pharma Group International | 1.52B | -0.71% | 5,538 | 82.08M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.48B | 3.05% | 793,214 | - |
| 140 | XNCR | Xencor, Inc. | 1.48B | 2.68% | 760,594 | 97.36M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 6.24% | 427,469 | - |
| 142 | ABSI | Absci Corporation | 1.44B | 6.94% | 1,983,191 | 1.84M |
| 143 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 27.08% | 5,043,989 | - |
| 144 | SVRA | Savara Inc. | 1.37B | 1.50% | 1,361,574 | - |
| 145 | AVLN | Avalyn Pharma Inc. | 1.36B | 7.82% | 176,667 | - |
| 146 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | 4.55% | 2,821,583 | 42.95M |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.29B | 5.04% | 563,720 | - |
| 148 | IMTX | Immatics N.V. | 1.28B | 3.99% | 442,263 | 43.00M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.27B | 11.49% | 1,687,316 | - |
| 150 | MNKD | MannKind Corporation | 1.26B | 4.21% | 5,118,133 | 360.78M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.26B | 2.74% | 299,214 | 8.28M |
| 152 | NVAX | Novavax, Inc. | 1.26B | 3.37% | 3,249,410 | 596.34M |
| 153 | ARDX | Ardelyx, Inc. | 1.24B | 0.60% | 3,130,088 | 427.68M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 0.98% | 217,677 | 1.30M |
| 155 | VOR | Vor Biopharma Inc. | 1.21B | 3.92% | 834,868 | - |
| 156 | WVE | Wave Life Sciences Ltd. | 1.18B | 4.53% | 2,261,633 | 65.37M |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.18B | 9.73% | 582,682 | - |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 4.11% | 766,890 | - |
| 159 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 3.78% | 89,902 | - |
| 160 | MGTX | MeiraGTx Holdings plc | 1.14B | 3.45% | 573,145 | 79.76M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.11B | 6.87% | 3,908,893 | 69.64M |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.10B | 3.52% | 555,437 | - |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 8.00% | 664,280 | - |
| 164 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 4.26% | 1,159,865 | - |
| 165 | APMD | Apnimed, Inc. | 1.02B | 2.84% | 298,425 | 120.15M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.02B | 6.92% | 1,709,689 | - |
| 167 | IVA | Inventiva S.A. | 1.02B | 6.12% | 1,024,369 | 7.94M |
| 168 | REPL | Replimune Group, Inc. | 1.00B | 0.08% | 6,086,244 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 980.29M | 2.66% | 1,157,455 | 59.00K |
| 170 | EYPT | EyePoint, Inc. | 978.43M | -6.04% | 2,929,693 | 7.61M |
| 171 | JANX | Janux Therapeutics, Inc. | 973.31M | 4.18% | 564,659 | 13.73M |
| 172 | ODTX | Odyssey Therapeutics, Inc. | 955.65M | 10.09% | 135,416 | 1.06M |
| 173 | OMER | Omeros Corporation | 936.54M | 3.03% | 1,645,946 | 9.89M |
| 174 | TBPH | Theravance Biopharma, Inc. | 874.86M | 0.06% | 420,208 | 109.78M |
| 175 | ANNX | Annexon, Inc. | 873.28M | 1.52% | 2,557,893 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 873.12M | 1.38% | 958,664 | 191.45M |
| 177 | GERN | Geron Corporation | 859.64M | 4.69% | 13,464,407 | 196.12M |
| 178 | SLDB | Solid Biosciences Inc. | 848.64M | 7.48% | 921,231 | - |
| 179 | KURA | Kura Oncology, Inc. | 840.69M | 3.05% | 1,005,500 | 71.64M |
| 180 | ACRS | Aclaris Therapeutics, Inc. | 835.19M | 8.14% | 2,576,983 | 8.37M |
| 181 | DSGN | Design Therapeutics, Inc. | 826.08M | 3.45% | 273,481 | - |
| 182 | SGP | SpyGlass Pharma, Inc. | 806.08M | 6.31% | 93,541 | - |
| 183 | MNPR | Monopar Therapeutics Inc. | 793.54M | 6.11% | 215,091 | - |
| 184 | TENX | Tenax Therapeutics, Inc. | 791.64M | -3.56% | 2,253,386 | - |
| 185 | AURA | Aura Biosciences, Inc. | 788.64M | 1.56% | 277,467 | - |
| 186 | DBVT | DBV Technologies S.A. | 788.61M | 0.96% | 330,458 | 5.04M |
| 187 | CADL | Candel Therapeutics, Inc. | 770.07M | 4.37% | 1,072,751 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 762.47M | 4.84% | 167,418 | - |
| 189 | PHAR | Pharming Group N.V. | 737.37M | 4.48% | 10,503 | 366.48M |
| 190 | AGMB | AgomAb Therapeutics NV | 725.42M | 8.95% | 87,469 | - |
| 191 | OCS | Oculis Holding AG | 724.05M | 0.84% | 310,990 | 1.40M |
| 192 | CTMX | CytomX Therapeutics, Inc. | 722.77M | 4.73% | 2,437,022 | 35.54M |
| 193 | CLYM | Climb Bio, Inc. | 719.19M | 6.35% | 1,031,567 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 716.03M | 3.39% | 334,134 | 276.79M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.55M | 7.52% | 507,088 | - |
| 196 | CBIO | Crescent Biopharma, Inc. | 701.08M | 10.15% | 258,791 | 11.88M |
| 197 | NGNE | Neurogene Inc. | 685.68M | 4.69% | 142,208 | 925.00K |
| 198 | GYRE | Gyre Therapeutics, Inc. | 685.66M | 0.65% | 63,211 | 117.05M |
| 199 | PHAT | Phathom Pharmaceuticals, Inc. | 671.18M | -5.90% | 2,189,755 | 239.66M |
| 200 | ACHV | Achieve Life Sciences, Inc. | 664.20M | 2.37% | 1,243,049 | - |
| 201 | IMMX | Immix Biopharma, Inc. | 664.20M | 10.81% | 1,868,836 | - |
| 202 | FTH | Faeth Therapeutics, Inc. | 657.36M | -6.73% | 651,930 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 3.26% | 4,997,357 | 22.00K |
| 204 | RGNX | REGENXBIO Inc. | 635.54M | 3.41% | 968,718 | 87.82M |
| 205 | NVCT | Nuvectis Pharma, Inc. | 633.66M | -6.94% | 592,173 | - |
| 206 | MDXG | MiMedx Group, Inc. | 622.40M | - | 1,806,926 | 355.17M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 621.89M | 4.57% | 1,284,325 | 122.29M |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | 4.81% | 1,065,000 | 151.40M |
| 209 | STTK | Shattuck Labs, Inc. | 607.31M | 8.64% | 1,445,790 | 1.00M |
| 210 | CTNM | Contineum Therapeutics, Inc. | 598.18M | -0.19% | 430,201 | - |
| 211 | ALT | Altimmune, Inc. | 597.04M | 2.33% | 8,162,984 | 36.00K |
| 212 | CRMD | CorMedix Inc. | 589.96M | -0.40% | 651,180 | 400.05M |
| 213 | ARVN | Arvinas, Inc. | 587.70M | 11.66% | 3,032,794 | 316.70M |
| 214 | MPLT | MapLight Therapeutics, Inc. | 586.77M | 3.11% | 847,437 | - |
| 215 | HELP | Cybin Inc. | 575.21M | 15.14% | 3,632,874 | - |
| 216 | RLMD | Relmada Therapeutics, Inc. | 573.75M | 3.21% | 1,196,703 | - |
| 217 | TECX | Tectonic Therapeutic, Inc. | 550.41M | 4.48% | 145,906 | - |
| 218 | ZURA | Zura Bio Limited | 540.54M | 3.08% | 702,657 | - |
| 219 | PRME | Prime Medicine, Inc. | 538.24M | 6.05% | 3,161,501 | 4.03M |
| 220 | ARTV | Artiva Biotherapeutics, Inc. | 537.87M | 2.88% | 411,205 | 251.00K |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 536.35M | 1.68% | 478,301 | 88.24M |
| 222 | SPRY | ARS Pharmaceuticals, Inc. | 528.29M | -2.56% | 1,931,419 | 98.99M |
| 223 | SLN | Silence Therapeutics plc | 527.60M | 4.59% | 518,578 | 839.00K |
| 224 | ANL | Adlai Nortye Ltd. | 520.00M | 0.08% | 179,343 | 5.00M |
| 225 | RZLT | Rezolute, Inc. | 519.20M | 1.22% | 2,541,342 | - |
| 226 | AUTL | Autolus Therapeutics plc | 518.98M | 7.14% | 4,209,870 | 92.62M |
| 227 | EIKN | Eikon Therapeutics, Inc. | 517.57M | 4.48% | 395,939 | - |
| 228 | VSTM | Verastem, Inc. | 510.55M | 2.11% | 1,789,826 | 49.59M |
| 229 | ASMB | Assembly Biosciences, Inc. | 509.00M | 4.26% | 90,954 | 71.10M |
| 230 | SLBT | SL Science Holding Limited | 497.81M | -6.38% | 164,797 | 3.27M |
| 231 | SGMT | Sagimet Biosciences Inc. | 493.40M | 11.75% | 1,705,970 | - |
| 232 | PROK | ProKidney Corp. | 492.36M | 4.49% | 698,919 | 889.00K |
| 233 | VALN | Valneva SE | 484.44M | 1.38% | 6,462 | 180.25M |
| 234 | QTTB | Q32 Bio Inc. | 480.84M | 6.49% | 728,090 | 53.74M |
| 235 | IKT | Inhibikase Therapeutics, Inc. | 476.83M | 10.41% | 1,255,013 | 1.00 |
| 236 | OVID | Ovid Therapeutics Inc. | 474.07M | 9.01% | 1,666,457 | 7.12M |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 472.99M | 3.60% | 563,651 | - |
| 238 | EVMN | Evommune, Inc. | 472.20M | 13.11% | 878,638 | 10.00M |
| 239 | CABA | Cabaletta Bio, Inc. | 451.66M | 2.97% | 2,710,071 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 448.28M | 2.96% | 218,798 | 16.72M |
| 241 | PRTA | Prothena Corporation plc | 444.48M | 1.92% | 329,912 | 57.94M |
| 242 | OCGN | Ocugen, Inc. | 443.46M | 4.80% | 6,551,201 | 4.47M |
| 243 | BNTC | Benitec Biopharma Inc. | 430.12M | 3.05% | 64,827 | - |
| 244 | LRMR | Larimar Therapeutics, Inc. | 429.01M | 3.27% | 1,681,528 | - |
| 245 | STRO | Sutro Biopharma, Inc. | 425.36M | 2.27% | 147,821 | 99.61M |
| 246 | EDIT | Editas Medicine, Inc. | 425.09M | 4.53% | 1,559,623 | 38.69M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.57M | 0.15% | 250,470 | - |
| 248 | SCTX | Scribe Therapeutics Inc. | 416.15M | 5.85% | 149,962 | 36.28M |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 404.63M | 4.89% | 604,703 | 9.01M |
| 250 | CCCC | C4 Therapeutics, Inc. | 399.15M | 3.14% | 2,519,664 | 34.86M |
| 251 | VTVT | vTv Therapeutics Inc. | 397.85M | -1.02% | 63,433 | 36.84M |
| 252 | PBYI | Puma Biotechnology, Inc. | 397.02M | 1.43% | 269,406 | 227.18M |
| 253 | ABEO | Abeona Therapeutics Inc. | 388.71M | 6.73% | 1,218,141 | 14.54M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 387.32M | 2.86% | 209,588 | 69.21M |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 376.13M | 1.95% | 406,388 | - |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 375.63M | 0.88% | 2,082,850 | - |
| 257 | AGEN | Agenus Inc. | 371.44M | 6.14% | 2,017,318 | 123.87M |
| 258 | UPB | Upstream Bio, Inc. | 369.51M | 5.76% | 1,362,389 | 3.32M |
| 259 | IPSC | Century Therapeutics, Inc. | 362.51M | 1.52% | 849,417 | 109.16M |
| 260 | PALI | Palisade Bio, Inc. | 359.31M | 6.70% | 1,646,432 | - |
| 261 | CMPX | Compass Therapeutics, Inc. | 356.57M | 5.04% | 3,050,285 | 850.00K |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 352.40M | 0.31% | 162,739 | - |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 351.19M | 5.42% | 166,420 | 51.00M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 347.39M | 4.95% | 788,633 | 26.87M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 346.28M | 5.00% | 917,006 | - |
| 266 | LYEL | Lyell Immunopharma, Inc. | 333.26M | 5.67% | 186,639 | 31.00K |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 326.81M | 4.08% | 13,879 | 370.61K |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 321.65M | -1.44% | 1,231 | 64.24M |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 320.52M | 1.91% | 727,298 | 217.78M |
| 270 | IRD | Opus Genetics, Inc. | 306.32M | 1.92% | 718,431 | 11.98M |
| 271 | FATE | Fate Therapeutics, Inc. | 299.56M | 2.80% | 6,440,797 | 6.32M |
| 272 | NMRA | Neumora Therapeutics, Inc. | 296.45M | -2.44% | 830,895 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 294.39M | 1.58% | 1,162,644 | 114.70K |
| 274 | AVXL | Anavex Life Sciences Corp. | 291.92M | 6.78% | 1,977,455 | - |
| 275 | OABI | OmniAb, Inc. | 289.95M | 2.04% | 352,541 | 28.94M |
| 276 | FULC | Fulcrum Therapeutics, Inc. | 289.93M | 2.43% | 2,349,306 | 80.00M |
| 277 | FHTX | Foghorn Therapeutics Inc. | 285.35M | 5.42% | 160,820 | 28.22M |
| 278 | IMRX | Immuneering Corporation | 284.67M | 5.52% | 764,699 | - |
| 279 | TTRX | Turn Therapeutics Inc. | 283.58M | 7.69% | 44,872 | - |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 279.21M | 0.90% | 857,838 | 14.78M |
| 281 | NAGE | Niagen Bioscience, Inc. | 276.95M | -1.70% | 1,029,812 | 130.42M |
| 282 | SLGL | Sol-Gel Technologies Ltd. | 276.21M | 3.06% | 40,094 | 18.47M |
| 283 | BCYC | Bicycle Therapeutics plc | 275.06M | 1.81% | 179,650 | 61.21M |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 269.79M | 1.75% | 805,243 | - |
| 285 | ALXO | ALX Oncology Holdings Inc. | 265.09M | 2.07% | 472,858 | - |
| 286 | IFRX | InflaRx N.V. | 262.18M | 1.71% | 888,689 | 33.82K |
| 287 | TRDA | Entrada Therapeutics, Inc. | 260.88M | -0.28% | 663,095 | 5.74M |
| 288 | PRQR | ProQR Therapeutics N.V. | 258.25M | 7.02% | 1,249,548 | 15.73M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 255.69M | 3.64% | 151,793 | 32.72M |
| 290 | SRZN | Surrozen, Inc. | 255.43M | 1.01% | 274,853 | 7.49M |
| 291 | MGNX | MacroGenics, Inc. | 247.90M | 2.09% | 875,964 | 157.08M |
| 292 | CNXU | Conexeu Sciences Inc. | 242.97M | 17.01% | 156,615 | - |
| 293 | CAPR | Capricor Therapeutics, Inc. | 241.49M | -0.71% | 4,218,706 | 11.13M |
| 294 | ADAG | Adagene Inc. | 240.50M | 0.28% | 113,184 | 7.67M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 236.82M | 2.41% | 297,963 | 1.78M |
| 296 | CHRS | Coherus Oncology, Inc. | 228.29M | 2.78% | 617,715 | 46.88M |
| 297 | TARA | Protara Therapeutics, Inc. | 225.38M | 1.01% | 425,772 | - |
| 298 | ACIU | AC Immune SA | 225.19M | 2.25% | 106,018 | 4.62M |
| 299 | CGEN | Compugen Ltd. | 225.11M | - | 344,934 | 74.00M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 222.66M | 4.55% | 471,036 | 7.15M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 216.01M | -1.19% | 210,540 | 3.93M |
| 302 | ANTX | AN2 Therapeutics, Inc. | 213.94M | 6.45% | 368,370 | - |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 210.63M | 5.98% | 151,044 | - |
| 304 | CLLS | Cellectis S.A. | 203.68M | 0.73% | 21,232 | 75.11M |
| 305 | KROS | Keros Therapeutics, Inc. | 203.23M | 1.38% | 276,933 | 15.01M |
| 306 | PYXS | Pyxis Oncology, Inc. | 200.20M | 3.95% | 926,185 | 13.86M |
| 307 | RNA | Atrium Therapeutics, Inc. | 197.40M | 1.85% | 136,994 | 36.68M |
| 308 | GALT | Galectin Therapeutics Inc. | 196.58M | -1.49% | 844,236 | - |
| 309 | ACOG | Alpha Cognition Inc. | 194.66M | 6.05% | 48,926 | 10.83M |
| 310 | HUMA | Humacyte, Inc. | 192.04M | 3.32% | 2,910,493 | 2.02M |
| 311 | IMUX | Immunic, Inc. | 191.38M | -0.35% | 249,707 | - |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | 2.16% | 716,163 | 76.38M |
| 313 | NBP | NovaBridge Biosciences | 190.82M | 2.48% | 250,173 | - |
| 314 | VYGR | Voyager Therapeutics, Inc. | 188.82M | 4.17% | 429,007 | 36.49M |
| 315 | NERV | Minerva Neurosciences, Inc. | 188.22M | 1.76% | 84,926 | - |
| 316 | DTIL | Precision BioSciences, Inc. | 187.84M | 3.12% | 383,123 | 45.07M |
| 317 | MDWD | MediWound Ltd. | 183.79M | 0.56% | 66,885 | 14.48M |
| 318 | ORMP | Oramed Pharmaceuticals Inc. | 182.53M | 1.59% | 242,712 | 2.00M |
| 319 | OTLK | Outlook Therapeutics, Inc. | 179.55M | 5.17% | 14,491,717 | 333.14K |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.70M | 5.06% | 359,377 | 17.56M |
| 321 | ARCT | Arcturus Therapeutics Holdings Inc. | 176.79M | 3.67% | 612,017 | 54.71M |
| 322 | NGEN | NervGen Pharma Corp. | 176.64M | 1.22% | 362,724 | - |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.16M | 5.38% | 264,907 | - |
| 324 | ARMP | Armata Pharmaceuticals, Inc. | 171.81M | -7.33% | 276,234 | 5.20M |
| 325 | ALEC | Alector, Inc. | 170.98M | 1.99% | 407,155 | 18.42M |
| 326 | IVVD | Invivyd, Inc. | 168.87M | 3.92% | 4,409,434 | 55.87M |
| 327 | IPHA | Innate Pharma S.A. | 165.93M | 3.78% | 2,338 | 10.57M |
| 328 | OKUR | OnKure Therapeutics, Inc. | 165.62M | 1.99% | 201,954 | - |
| 329 | KRRO | Korro Bio, Inc. | 163.70M | 5.68% | 132,436 | 3.84M |
| 330 | YDES | YD Bio Limited | 163.14M | 0.87% | 5,497 | 510.36K |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 161.79M | 2.75% | 283,352 | - |
| 332 | NKTX | Nkarta, Inc. | 161.69M | 5.12% | 750,840 | - |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 160.93M | 1.73% | 1,607,720 | 225.00K |
| 334 | MIST | Milestone Pharmaceuticals Inc. | 159.18M | 4.46% | 1,323,089 | 1.78M |
| 335 | LENZ | LENZ Therapeutics, Inc. | 158.34M | 1.10% | 844,139 | 20.99M |
| 336 | AARD | Aardvark Therapeutics, Inc. | 157.73M | 2.12% | 131,978 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 155.71M | 4.67% | 1,335,780 | 11.20M |
| 338 | MOLN | Molecular Partners AG | 154.76M | 0.97% | 254 | 856.30K |
| 339 | INDP | Indaptus Therapeutics, Inc. | 154.01M | 3.82% | 104,935 | - |
| 340 | MENS | Jyong Biotech Ltd. | 151.44M | 2.00% | 54,290 | - |
| 341 | CNTN | Canton Strategic Holdings, Inc. | 147.30M | -4.50% | 900,440 | - |
| 342 | CBUS | Cibus, Inc. | 146.56M | 1.59% | 138,755 | 4.29M |
| 343 | EQ | Equillium, Inc. | 142.89M | 2.73% | 438,533 | 4.39M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 141.62M | 2.17% | 858,383 | - |
| 345 | ENTX | Entera Bio Ltd. | 141.46M | -3.04% | 841,548 | 42.00K |
| 346 | KZIA | Kazia Therapeutics Limited | 140.67M | -0.81% | 152,208 | 1.27M |
| 347 | PEPG | PepGen Inc. | 133.50M | 2.66% | 357,168 | - |
| 348 | HURA | TuHURA Biosciences, Inc. | 133.10M | -2.34% | 199,522 | - |
| 349 | CNTB | Connect Biopharma Holdings Limited | 130.34M | 5.08% | 267,723 | 233.00K |
| 350 | CDXS | Codexis, Inc. | 129.98M | -1.38% | 687,823 | 78.09M |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 127.83M | -5.86% | 1,256,699 | 2.29M |
| 352 | SPRB | Spruce Biosciences, Inc. | 127.32M | 7.23% | 63,239 | 697.00K |
| 353 | NAUT | Nautilus Biotechnology, Inc. | 125.38M | -2.45% | 1,866,874 | 190.00K |
| 354 | GNLX | Genelux Corporation | 125.23M | -5.37% | 787,196 | 8.00K |
| 355 | TLSA | Tiziana Life Sciences Ltd | 125.12M | -0.18% | 577,802 | - |
| 356 | PMN | ProMIS Neurosciences, Inc. | 121.69M | -4.03% | 18,750 | - |
| 357 | SEER | Seer, Inc. | 121.51M | -1.34% | 288,224 | 15.17M |
| 358 | VANI | Vivani Medical, Inc. | 120.73M | 5.26% | 157,405 | - |
| 359 | ENGN | enGene Therapeutics Inc. | 118.91M | 0.28% | 640,751 | - |
| 360 | ANIX | Anixa Biosciences, Inc. | 116.02M | - | 194,713 | - |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 111.81M | 2.33% | 1,120,195 | 3.17M |
| 362 | CUE | Cue Biopharma, Inc. | 111.73M | -1.00% | 187,717 | 32.73M |
| 363 | GUTS | Fractyl Health, Inc. | 108.67M | 1.15% | 706,268 | 3.00K |
| 364 | COYA | Coya Therapeutics, Inc. | 107.20M | 3.16% | 145,659 | 7.94M |
| 365 | YARW | Yarrow Bioscience, Inc. | 106.27M | 12.99% | 39,738 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 105.58M | 1.83% | 51,352 | - |
| 367 | KLRS | Kalaris Therapeutics, Inc. | 102.78M | 6.67% | 133,652 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 102.00M | 2.59% | 917,200 | 70.00M |
| 369 | ICCC | ImmuCell Corporation | 100.15M | 0.27% | 27,581 | 29.93M |
| 370 | HRTX | Heron Therapeutics, Inc. | 96.82M | 0.02% | 1,461,046 | 150.71M |
| 371 | ONCY | Oncolytics Biotech Inc. | 96.74M | 4.58% | 578,640 | - |
| 372 | ACET | Adicet Bio, Inc. | 96.71M | -0.32% | 95,392 | - |
| 373 | ALDX | Aldeyra Therapeutics, Inc. | 93.50M | 1.31% | 975,520 | - |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 92.94M | 3.05% | 28,448 | 37.16M |
| 375 | PTHS | Pelthos Therapeutics Inc. | 92.80M | -0.52% | 132,726 | 27.70M |
| 376 | FBIO | Fortress Biotech, Inc. | 90.36M | -1.45% | 992,272 | 66.16M |
| 377 | NTHI | NeOnc Technologies Holdings, Inc. | 88.95M | -0.87% | 57,428 | 39.99K |
| 378 | BMEA | Biomea Fusion, Inc. | 88.93M | 2.50% | 622,591 | - |
| 379 | GOSS | Gossamer Bio, Inc. | 88.73M | 4.55% | 14,760,336 | 55.54M |
| 380 | CGTX | Cognition Therapeutics, Inc. | 88.25M | 10.61% | 733,817 | - |
| 381 | NRXS | NeurAxis, Inc. | 86.81M | 6.37% | 159,703 | 4.28M |
| 382 | OKYO | OKYO Pharma Limited | 86.07M | -1.80% | 48,116 | - |
| 383 | ATHE | Alterity Therapeutics Limited | 85.66M | -1.41% | 2,301 | 4.43M |
| 384 | PYPD | PolyPid Ltd. | 85.32M | 2.06% | 165,851 | - |
| 385 | RLYB | Rallybio Corporation | 84.56M | 0.06% | 44,900 | 858.00K |
| 386 | MAIA | MAIA Biotechnology, Inc. | 82.69M | 3.03% | 384,213 | - |
| 387 | ANVS | Annovis Bio, Inc. | 79.55M | 8.72% | 808,963 | - |
| 388 | TELO | Telomir Pharmaceuticals, Inc. | 79.09M | -7.26% | 81,651 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 79.02M | 2.57% | 42,279 | 23.14M |
| 390 | CSBR | Champions Oncology, Inc. | 75.72M | -5.38% | 18,688 | 59.43M |
| 391 | GANX | Gain Therapeutics, Inc. | 75.07M | 0.57% | 282,505 | - |
| 392 | ELOX | Eloxx Pharmaceuticals, Inc. | 74.39M | -0.11% | 44,592 | - |
| 393 | ELTX | Elicio Therapeutics, Inc. | 74.11M | 10.49% | 692,406 | - |
| 394 | OSTX | OS Therapies Incorporated | 72.60M | 5.16% | 347,275 | - |
| 395 | IBIO | iBio, Inc. | 72.53M | 2.82% | 486,185 | 300.00K |
| 396 | LONA | LeonaBio, Inc. | 71.95M | 5.76% | 4,144 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 71.22M | 6.96% | 751,917 | 61.19M |
| 398 | XBIT | XBiotech Inc. | 68.29M | 0.22% | 28,410 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 66.77M | - | 184,297 | - |
| 400 | CING | Cingulate Inc. | 66.00M | 1.45% | 233,769 | - |
| 401 | ALPS | Alps Group Inc | 65.96M | -0.13% | 32,389 | 3.74M |
| 402 | RNTX | Rein Therapeutics Inc. | 65.33M | 2.44% | 483,769 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 65.02M | 0.96% | 259,712 | - |
| 404 | IMA | ImageneBio, Inc. | 64.40M | 1.24% | 7,232 | 800.00K |
| 405 | MNOV | MediciNova, Inc. | 63.99M | -2.26% | 82,924 | 596.64K |
| 406 | HYFT | MindWalk Holdings Corp. | 63.90M | 0.74% | 171,330 | 11.43M |
| 407 | CRDF | Cardiff Oncology, Inc. | 63.51M | -0.55% | 646,831 | 525.00K |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 62.40M | 4.46% | 410,245 | - |
| 409 | BOLD | Boundless Bio, Inc. | 60.76M | 5.25% | 377,257 | - |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 60.20M | 4.68% | 72,495 | - |
| 411 | CNTX | Context Therapeutics Inc. | 57.13M | 2.93% | 945,361 | - |
| 412 | INKT | MiNK Therapeutics, Inc. | 55.15M | 3.55% | 10,574 | - |
| 413 | INO | Inovio Pharmaceuticals, Inc. | 54.56M | -4.84% | 3,991,944 | 65.34K |
| 414 | XLO | Xilio Therapeutics, Inc. | 54.38M | 0.44% | 20,544 | 53.48M |
| 415 | ATYR | aTyr Pharma, Inc. | 51.89M | 7.56% | 974,955 | 190.00K |
| 416 | MREO | Mereo BioPharma Group plc | 51.41M | 2.09% | 361,277 | 500.00K |
| 417 | MCRB | Seres Therapeutics, Inc. | 50.84M | 4.37% | 40,456 | 1.15M |
| 418 | INMB | INmune Bio Inc. | 50.78M | 3.24% | 414,336 | 50.00K |
| 419 | TIL | Instil Bio, Inc. | 49.17M | 0.42% | 12,541 | - |
| 420 | IMMP | Immutep Limited | 48.71M | 3.44% | 313,282 | 5.28M |
| 421 | FLNA | Filana Therapeutics, Inc. | 48.13M | -3.26% | 394,249 | - |
| 422 | TCRX | TScan Therapeutics, Inc. | 48.13M | 1.81% | 796,246 | 9.14M |
| 423 | EDSA | Edesa Biotech, Inc. | 47.66M | 2.49% | 36,155 | - |
| 424 | IBO | Impact BioMedical Inc. | 47.44M | 0.23% | 140,664 | 39.00K |
| 425 | RNXT | RenovoRx, Inc. | 46.90M | -1.89% | 401,844 | 1.49M |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | - | 103,351 | 22.33M |
| 427 | VRXA | Veraxa Biotech AG | 45.39M | -1.64% | 150,155 | - |
| 428 | KPTI | Karyopharm Therapeutics Inc. | 44.42M | -0.51% | 3,792,123 | 151.12M |
| 429 | EXOZ | eXoZymes, Inc. | 42.09M | 0.43% | 3,528 | -700.00 |
| 430 | HYPD | Hyperion DeFi, Inc. | 41.38M | 2.63% | 171,652 | 1.04M |
| 431 | BYSI | BeyondSpring Inc. | 40.71M | -15.38% | 110,232 | 1.88M |
| 432 | PDSB | PDS Biotechnology Corporation | 40.19M | 0.78% | 292,017 | - |
| 433 | DYAI | Dyadic International, Inc. | 39.35M | 1.89% | 83,162 | 3.81M |
| 434 | APLM | Apollomics, Inc. | 38.60M | 1.88% | 4,076 | 8.84M |
| 435 | VERU | Veru Inc. | 38.04M | 4.87% | 256,687 | 16.89M |
| 436 | CRVO | CervoMed Inc. | 37.87M | 7.69% | 680,690 | 2.09M |
| 437 | RADX | Radiopharm Theranostics Limited | 35.92M | -6.11% | 81,786 | 10.86M |
| 438 | GRCE | Grace Therapeutics, Inc. | 35.48M | 4.81% | 100,502 | - |
| 439 | LTRN | Lantern Pharma Inc. | 35.09M | 5.36% | 82,933 | - |
| 440 | NTRB | Nutriband Inc. | 34.64M | 1.42% | 6,994 | 1.80M |
| 441 | NNVC | NanoViricides, Inc. | 34.63M | -1.94% | 296,954 | - |
| 442 | ENLV | Enlivex Ltd. | 33.91M | -2.76% | 467,428 | - |
| 443 | LITS | Lite Strategy, Inc. | 32.13M | -3.76% | 150,431 | - |
| 444 | SER | Serina Therapeutics, Inc. | 32.09M | 3.88% | 44,981 | 130.00K |
| 445 | ESLA | Estrella Immunopharma, Inc. | 30.30M | 0.57% | 24,247 | - |
| 446 | GNTA | Genenta Science S.p.A. | 29.96M | -9.93% | 108,186 | - |
| 447 | TVGN | Tevogen Inc. | 29.54M | -0.28% | 9,070 | - |
| 448 | ALGS | Aligos Therapeutics, Inc. | 29.39M | 3.26% | 81,446 | 4.71M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 29.13M | 0.30% | 143,947 | - |
| 450 | KYNB | Kyntra Bio, Inc. | 28.01M | 2.37% | 8,795 | 7.44M |
| 451 | ABVC | ABVC BioPharma, Inc. | 27.04M | 2.88% | 153,442 | 797.92K |
| 452 | QNCX | Quince Therapeutics, Inc. | 26.81M | 9.77% | 26,046 | - |
| 453 | ACTU | Actuate Therapeutics, Inc. | 26.80M | 5.66% | 309,745 | - |
| 454 | ATNM | Actinium Pharmaceuticals, Inc. | 25.41M | -0.18% | 92,119 | 90.00K |
| 455 | IGC | IGC Pharma, Inc. | 24.82M | 1.18% | 307,699 | 1.11M |
| 456 | EVAX | Evaxion A/S | 24.60M | 5.73% | 10,882 | 7.53M |
| 457 | CVM | CEL-SCI Corporation | 23.77M | 8.80% | 269,892 | - |
| 458 | LGVN | Longeveron Inc. | 23.45M | 1.38% | 777,957 | 1.22M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 23.07M | -5.87% | 83,747 | 14.97M |
| 460 | NEUP | Neuphoria Therapeutics Inc. | 21.02M | -1.02% | 41,971 | -13.27K |
| 461 | NXTC | NextCure, Inc. | 20.88M | 31.36% | 536,111 | - |
| 462 | ALLR | Allarity Therapeutics, Inc. | 20.84M | 3.15% | 117,387 | 345.00K |
| 463 | MRKR | Marker Therapeutics, Inc. | 20.51M | 0.82% | 34,007 | 3.55M |
| 464 | CLRB | Cellectar Biosciences, Inc. | 20.46M | -3.76% | 38,789 | - |
| 465 | CELU | Celularity Inc. | 20.36M | 6.54% | 77,813 | 26.55M |
| 466 | SKYE | Skye Bioscience, Inc. | 20.21M | -1.57% | 168,172 | - |
| 467 | HOWL | Werewolf Therapeutics, Inc. | 20.15M | 12.79% | 605,036 | 21.00M |
| 468 | DARE | Daré Bioscience, Inc. | 20.07M | 4.69% | 133,805 | 1.16M |
| 469 | ATOS | Atossa Therapeutics, Inc. | 19.89M | 6.45% | 54,974 | - |
| 470 | PLRZ | Polyrizon Ltd. | 19.09M | -3.68% | 222,886 | - |
| 471 | TVRD | Tvardi Therapeutics, Inc. | 19.04M | 0.50% | 393,475 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 18.63M | 9.76% | 718,798 | - |
| 473 | NCEL | NewcelX Ltd. | 18.57M | 0.88% | 5,707 | - |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 18.38M | 11.33% | 151,535 | - |
| 475 | GRDX | GridAI Technologies Corp. | 18.30M | -5.50% | 55,551 | - |
| 476 | LPCN | Lipocine Inc. | 17.56M | 0.95% | 131,357 | 1.57M |
| 477 | QNTM | Quantum BioPharma Ltd. | 17.47M | -5.90% | 229,970 | - |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 17.09M | 4.45% | 282,113 | 5.61M |
| 479 | PLUR | Pluri Inc. | 16.83M | -0.95% | 35,683 | 1.08M |
| 480 | OSRH | OSR Health, Inc. | 16.18M | 3.34% | 258,461 | 2.63M |
| 481 | KTTA | Pasithea Therapeutics Corp. | 15.37M | 3.00% | 125,636 | - |
| 482 | HIND | Vyome Holdings, Inc. | 15.23M | 0.23% | 5,905 | 152.72K |
| 483 | MLEC | Moolec Science SA | 14.99M | 3.35% | 598 | 7.83M |
| 484 | CYCN | Cyclerion Therapeutics, Inc. | 14.89M | 0.57% | 6,368 | 1.99M |
| 485 | PASG | Passage Bio, Inc. | 14.85M | 3.12% | 37,615 | - |
| 486 | PTN | Palatin Technologies, Inc. | 14.77M | -1.58% | 11,052 | 12.88M |
| 487 | KALA | KALA BIO, Inc. | 13.81M | -5.11% | 127,610 | - |
| 488 | BIVI | BioVie Inc. | 13.80M | 12.96% | 397,681 | - |
| 489 | AKTX | Akari Therapeutics, Plc | 13.64M | 5.84% | 8,711 | - |
| 490 | COCP | Cocrystal Pharma, Inc. | 13.51M | 4.28% | 116,095 | 225.00K |
| 491 | TPST | Tempest Therapeutics, Inc. | 13.14M | 1.38% | 67,870 | - |
| 492 | BLRX | BioLineRx Ltd. | 13.05M | 3.88% | 3,960 | 1.40M |
| 493 | ICU | SeaStar Medical Holding Corporation | 12.83M | -0.16% | 66,519 | 1.44M |
| 494 | CALC | CalciMedica, Inc. | 12.56M | 5.62% | 197,959 | - |
| 495 | BIOT | Instinct Bio Technical Company Holdings Inc. | 12.34M | -1.54% | 644,597 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 12.31M | 2.91% | 293,790 | - |
| 497 | VTGN | Vistagen Therapeutics, Inc. | 12.31M | 22.45% | 117,919,654 | 1.27M |
| 498 | PBM | Psyence Biomedical Ltd. | 12.17M | 1.27% | 33,107 | - |
| 499 | CMMB | Chemomab Therapeutics Ltd. | 12.10M | 3.70% | 38,587 | - |
| 500 | SNTI | Senti Biosciences Holdings, Inc. | 11.99M | 4.03% | 156,740 | 38.00K |